These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16368730)

  • 21. Olfactory hallucinations in primary headache disorders: case series and literature review.
    Coleman ER; Grosberg BM; Robbins MS
    Cephalalgia; 2011 Oct; 31(14):1477-89. PubMed ID: 21945891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 13-year long-term outcome study of elderly with chronic daily headache.
    Fuh JL; Wang SJ; Lu SR; Tsai PH; Lai TH; Lai KL
    Cephalalgia; 2008 Oct; 28(10):1017-22. PubMed ID: 18624806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a pine bark extract and antioxidant vitamin combination product as therapy for migraine in patients refractory to pharmacologic medication.
    Chayasirisobhon S
    Headache; 2006 May; 46(5):788-93. PubMed ID: 16643582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behçet's disease as a systemic disease.
    Mat MC; Sevim A; Fresko I; Tüzün Y
    Clin Dermatol; 2014; 32(3):435-42. PubMed ID: 24767193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esophageal involvement in Behcet's disease.
    Houman MH; Ben Ghorbel I; Lamloum M; Khanfir M; Braham A; Haouet S; Sayem N; Lassoued H; Miled M
    Yonsei Med J; 2002 Aug; 43(4):457-60. PubMed ID: 12205734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and burden of headache and migraine in Germany.
    Radtke A; Neuhauser H
    Headache; 2009 Jan; 49(1):79-89. PubMed ID: 19125877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of diagnostic ('classification') criteria in Behçet's disease--towards internationally agreed criteria. The International Study Group for Behçet's disease.
    Br J Rheumatol; 1992 May; 31(5):299-308. PubMed ID: 1581771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuro-Behçet syndrome.
    Saip S; Akman-Demir G; Siva A
    Handb Clin Neurol; 2014; 121():1703-23. PubMed ID: 24365442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical correlates and diagnostic utility of osmophobia in migraine.
    Wang YF; Fuh JL; Chen SP; Wu JC; Wang SJ
    Cephalalgia; 2012 Dec; 32(16):1180-8. PubMed ID: 23038716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aura-related symptoms associated with cluster headache: outcomes of a LUCA substudy].
    Wilbrink LA; Cheung C; Weller C; Ferrari M; Haan J
    Ned Tijdschr Geneeskd; 2013; 157(1):A5306. PubMed ID: 23298724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study.
    Rabe K; Pageler L; Gaul C; Lampl C; Kraya T; Foerderreuther S; Diener HC; Katsarava Z
    Cephalalgia; 2013 Feb; 33(3):202-7. PubMed ID: 23093541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presentation of headache in neuro-Behçet's disease: a case-series.
    Kale N; Agaoglu J; Icen M; Yazici I; Tanik O
    Headache; 2009 Mar; 49(3):467-70. PubMed ID: 19267789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The "repeater" phenomenon in migraine patients: a clinical and psychometric study.
    Villani V; Di Stani F; Vanacore N; Scattoni L; Cerbo R; Bruti G
    Headache; 2010 Mar; 50(3):348-56. PubMed ID: 20039961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistant bipolar disorder precipitated by Behcet's syndrome.
    Alevizos B; Anagnostara C; Christodoulou GN
    Bipolar Disord; 2004 Jun; 6(3):260-3. PubMed ID: 15117405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
    Buse DC; Manack AN; Fanning KM; Serrano D; Reed ML; Turkel CC; Lipton RB
    Headache; 2012; 52(10):1456-70. PubMed ID: 22830411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation and therapeutic approaches of voiding and erectile dysfunction in neurological Behçet's syndrome.
    Erdoğru T; Koçak T; Serdaroğlu P; Kadioğlu A; Tellaloğlu S
    J Urol; 1999 Jul; 162(1):147-53. PubMed ID: 10379759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.